Reprogramming of human γδ T cells by expression of an anti-CD19 TCR fusion construct (εTRuC) to enhance tumor killing
In conclusion, the generation and use of γδ εTRuC T cells might be a new approach for cancer immunotherapy.PMID:38149982 | DOI:10.1093/jleuko/qiad128
Source: Journal of Leukocyte Biology - Category: Hematology Authors: Claudia Juraske Sonia M Krissmer Evelyn S Teuber Maria A Parigiani Juliane Strietz Daniela Wesch Dieter Kabelitz Susana Minguet Wolfgang W Schamel Source Type: research
More News: Adenocarcinoma | Biology | Cancer | Cancer & Oncology | Colon Cancer | Colorectal Cancer | Hematology | Immunotherapy | Nutrition | Vitamin C | Vitamins